// App-Quantinova.ai

: Dose Prednisolone with Pirfenidone in Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • S. Matsubayashi

Principal Investigators

  • H. Takumida

  • H. Watanabe

  • S. Matsumoto

  • Y. Kusaba

  • T. Katsuno

  • T. Kakuwa

  • Y. Tsujimoto

  • K. Sakamoto

  • M. Hashimoto

  • S. Ishii

  • E. Morino

  • M. Suzuki

  • J. Takasaki

  • G. Naka

  • M. Iikura

  • Y. Takeda

  • H. Sugiyama

Medical Centers

  • Department of Gastroenterology, National Center for Global Health and Medicine, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Prednisolone

  • Pirfenidone

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A